Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies-Reference-Cited by-同舟云学术

Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies

Published:2019-07 Issue:7 Volume:25 Page:1465-1471
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bouard Louise,Guillaume Thierry,Peterlin Pierre^ORCID,Garnier Alice,Le Bourgeois Amandine,Duquenne Alix,Mahe Beatrice,Dubruille Viviane,Blin Nicolas,Touzeau Cyrille,Gastinne Thomas,Le Bris Yannick,Lok Anne,Bonnet Antoine,Le Gouill Steven,Moreau Philippe,Bene Marie C,Chevallier Patrice

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference40 articles.

1. Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report;Passweg;Bone Marrow Transplant,2018

2. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

3. Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies;Chevallier;Oncotarget,2018

4. Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in patients allografted in remission for acute myeloid leukemia: a retrospective study on behalf of the SFGM-TC;Le Bourgeois;Blood,2017

5. The role of clofarabine in acute myeloid leukemia;Ghanem;Leuk Lymph,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Cryopreservation on Hematopoietic Stem Cell Engraftment and Post-transplant Outcome During the COVID-19 Pandemic;In Vivo;2024

2. Prognostic Factors Contributing to the Survival of Hematopoietic Stem Cell Transplantation in the General Population with Leukemia: a Systematic Review;Regenerative Engineering and Translational Medicine;2022-08-12

3. Phase I/II multisite trial of optimally dosed clofarabine and low‐dose TBI for hematopoietic cell transplantation in acute myeloid leukemia;American Journal of Hematology;2019-11-08